Grantham, Mayo, Van Otterloo & Co (GMO)’s iShares Core S&P 500 ETF IVV Stock Holding History
Bought
Maintained
Sold
Other funds holding IVV
CM
Grantham, Mayo, Van Otterloo & Co (GMO)'s IVV Position: Q1 2025 in Review
Grantham, Mayo, Van Otterloo & Co (GMO) sold out of iShares Core S&P 500 ETF (IVV) in Q1 2025, closing a stake of 218,200 shares — an estimated $128M sold.
Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in IVV in Q4 2019 and held it in 6 quarters. The position peaked at $128M in Q4 2024. 3,563 funds tracked by Wall St. Rank hold IVV as of Q1 2025.
- Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining iShares Core S&P 500 ETF position as of Q1 2025 after selling out during the quarter.
- Grantham, Mayo, Van Otterloo & Co (GMO) sold 218,200 iShares Core S&P 500 ETF shares in Q1 2025, an estimated $128M.
- Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in iShares Core S&P 500 ETF in Q4 2019 and held it in 6 quarters.
- Grantham, Mayo, Van Otterloo & Co (GMO)'s iShares Core S&P 500 ETF position peaked at $128M in Q4 2024.
- 3,563 funds tracked by Wall St. Rank held iShares Core S&P 500 ETF as of Q1 2025.
Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q1 2025, filed 14 May 2025.